The antiviral 2'.5'-oligoadenylate synthetase is persistently activated in Type 1 diabetes

V. Bonnevie-Nielsen, P.M. Martensen, J. Justesen, K.O. Kyvik, B. Kristensen, K. Levin, H. Beck-Nielsen, T. Dyrberg

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Adgang til dokumentet

@article{9942445434ee42ed816b021ab925a1c1,

title = "The antiviral 2'.5'-oligoadenylate synthetase is persistently activated in Type 1 diabetes",

author = "V. Bonnevie-Nielsen and P.M. Martensen and J. Justesen and K.O. Kyvik and B. Kristensen and K. Levin and H. Beck-Nielsen and T. Dyrberg",

year = "2000",

doi = "10.1006/clim.2000.4874",

language = "English",

volume = "96",

pages = "11--18",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - The antiviral 2'.5'-oligoadenylate synthetase is persistently activated in Type 1 diabetes

AU - Bonnevie-Nielsen, V.

AU - Martensen, P.M.

AU - Justesen, J.

AU - Kyvik, K.O.

AU - Kristensen, B.

AU - Levin, K.

AU - Beck-Nielsen, H.

AU - Dyrberg, T.

PY - 2000

Y1 - 2000

U2 - 10.1006/clim.2000.4874

DO - 10.1006/clim.2000.4874

M3 - Article

SN - 1521-6616

VL - 96

SP - 11

EP - 18

JO - Clinical Immunology

JF - Clinical Immunology

IS - 1

ER -